New jab to alleviate misery of back pain

Image
ANI London
Last Updated : Dec 13 2013 | 3:25 PM IST

A new jab, that could end the agony of back pain, has got an approval from European regulators.

During experiments, the Cimzia jabs showed rapid improvements in pain, stiffness and mobility, the Daily Express reported.

The breakthrough fortnightly injection can allow back pain sufferers to enjoy activities and run errands they couldn't do before.

Sufferers can experience increased pain when resting which improves with exercise, painful inflammation of tendons and ligaments, arthritis, sore red eyes known as uveitis, and inflammatory bowel disease.

Dr Stefan Siebert, a senior lecturer in rheumatology at the University of Glasgow, said with advances in imaging technology, better diagnostic criteria and new treatments they now have the opportunity to improve patients' symptoms and avert long-term disability.

Cimzia is administered every fortnight but after two jabs it can be administered monthly.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 13 2013 | 3:15 PM IST

Next Story